Back to all studies
RecruitingNCT05883540

Lysergic Acid Diethylamide (LSD) in Palliative Care: a Active-placebo Controlled Phase II Study (LPC-Study)

The registry lists this study as recruiting. Study locations are listed in Switzerland. Confirm recruitment at each site. It is testing lysergic Acid Diethylamide Tartrate for Palliative Care; Pain; Anxiety; Depression; Demoralization; Psychological Distress; Quality of Life; Caregiver Burden; Fear of Death; Existential Distress.

Anxiety, Depression, ...DrugOver 22 Years
In plain English

Key information made simple

What is this study testing?

This study is testing whether Lysergic Acid Diethylamide Tartrate may be useful for adults experiencing anxiety.

What would participation involve?

Participants may receive Lysergic Acid Diethylamide Tartrate, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Switzerland.

Who is it mainly for?

This study appears to be mainly for adults with anxiety.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: June 9, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
University Hospital, Basel, Switzerland
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Switzerland
Age range
Over 22 Years
Official registry ID
NCT05883540
Official title
Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)

Want help reviewing this study?

Loading the security check...
Study ID: NCT05883540. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Switzerland · 4 sites
  • University Hospital Basel, Division of Clinical Pharmacology and Toxicology
    Basel
    Site status: Recruiting
  • University Hospital Geneva, Palliative medicine department
    Collonge-Bellerive
    Site status: Recruiting
  • Spital Uster AG, Division of Internal Medicine
    Uster
    Site status: Recruiting
  • University Hospital Zurich, Clinic for Radio-Oncology, Competence Centre Palliative Care
    Zurich
    Site status: Recruiting
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with anxiety. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Lysergic Acid Diethylamide Tartrate. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with anxiety; age range: Over 22 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

Does a loved one or caregiver need to be involved?

The public registry appears to mention a loved one, caregiver, or family involvement. Ask whether that person must participate, provide information, attend visits, or simply be available if needed. The study team must confirm what is required.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by University Hospital, Basel, Switzerland, which appears to be a hospital or academic medical center. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me